WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals International PLC Stock Ownership - Who owns Kiniksa Pharmaceuticals International?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kiniksa Pharmaceuticals International PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sanj K. PatelCEO;Chair2026-11-0426,918$96.05
$2.59MSell
Sanj K. PatelCEO;Chair2026-11-0429,845$95.48
$2.85MSell
Sanj K. PatelCEO;Chair2026-11-0481,742$94.20
$7.70MSell
Sanj K. PatelCEO;Chair2026-11-0411,335$93.54
$1.06MSell
Sanj K. PatelCEO;Chair2026-11-041,460$92.35
$134.83kSell
Sanj K. PatelCEO;Chair2026-11-04145,763$17.92
$2.61MBuy
Sanj K. PatelCEO;Chair2026-11-034,584$94.25
$432.04kSell
Sanj K. PatelCEO;Chair2026-11-031,214$90.77
$110.19kSell
Sanj K. PatelCEO;Chair2026-11-0389,089$8.83
$786.66kBuy
Sanj K. PatelCEO;Chair2026-11-0341,237$17.92
$738.97kBuy

1 of 17

KNSA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KNSA insiders and whales buy or sell their stock.

KNSA Shareholders

What type of owners hold Kiniksa Pharmaceuticals International PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP3.51%2,759,734$259.03MInsider
Sanj K. Patel2.91%2,283,157$214.30MInsider
Cormorant Asset Management LP2.20%1,731,442$162.51MInsider
James E. Flynn1.56%1,226,890$115.16MInsider
Thomas W. Beetham0.38%297,523$27.93MInsider
Stephen F. Mahoney0.15%116,187$10.91MInsider
Thomas Malley0.11%87,312$8.20MInsider
Chris Heberlig0.10%79,589$7.47MInsider
Carsten Boess0.10%79,589$7.47MInsider
John F. Paolini0.09%69,922$6.56MInsider

1 of 3

KNSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KNSA0.06%11.30%Net SellingNet Selling
CYTK0.12%10.96%Net SellingNet Selling
CAI0.05%80.66%Net BuyingNet Buying
PRAX0.12%50.28%Net Selling
RYTM0.11%13.44%Net SellingNet Selling
View Top Biotech Stocks

Kiniksa Pharmaceuticals International Stock Ownership FAQ

Who owns Kiniksa Pharmaceuticals International?

Kiniksa Pharmaceuticals International (NASDAQ: KNSA) is owned by 0.06% institutional shareholders, 11.30% Kiniksa Pharmaceuticals International insiders, and 88.64% retail investors. Baker Bros Advisors LP is the largest individual Kiniksa Pharmaceuticals International shareholder, owning 2.76M shares representing 3.51% of the company. Baker Bros Advisors LP's Kiniksa Pharmaceuticals International shares are currently valued at $259.03M.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals International stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.